Cancer Care Ontario | Cancer Care Ontario

The Role of Aromatase Inhibitors in the Treatment of Postmenopausal Women with Metastatic Breast Cancer

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

The Role of Porfimer Sodium (PhotofrinTM) in the Palliative Treatment of Esophageal Cancer

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

The Role of Trastuzumab (Herceptin) in the Treatment of Women with HER2/neu-overexpressing Metastatic Breast Cancer

The Role of Bevacizumab (Avastin®) Combined with Chemotherapy in the Treatment of Patients with Advanced Colorectal Cancer

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Temozolomide Monotherapy for the Treatment of Patients with Glioblastoma that has Relapsed or Progressed Following Prior Therapy

The Role of Oxaliplatin Combined with 5-Fluorouracil and Folinic Acid in the First and Second-line Treatment of Advanced Colorectal Cancer

Treatment with Fludarabine for Patients with Follicular and Other Low Grade Non-Hodgkin's Lymphoma and Waldenstrom's Macroglobulinemia

The Role of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Excluding Nasopharynx)